KING OF PRUSSIA, Pa., Feb. 21, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences:
Monday, March 4, 2024 at 9:50am (ET), at the TD Cowen 44th Annual Health Care Conference in Boston, MA
Tuesday, March 12, 2024 at 1:05pm (ET) at the Barclays 26th Annual Global Healthcare Conference in Miami Beach, FL.
Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.
Universal Health Services, Inc. is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico, and the United Kingdom.
| Last Trade: | US$223.87 |
| Daily Change: | 1.27 0.57 |
| Daily Volume: | 981,670 |
| Market Cap: | US$12.360B |
October 29, 2025 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
